Biomonitor’s mission is to develop clinically useful methods to:
- monitor therapies with biopharmaceuticals
- support the biopharmaceutical industry in drug development programs
- demonstrate the immunogenic properties of biopharmaceuticals
The company was founded on the basis of many years of basic research and clinical experience within the fields of innate and adaptive immunity and inflammation.
Today, the biopharmaceutical industry is growing rapidly, and monitoring interferons and anti-TNF therapies are examples of growth areas where evidence is accumulating that the individualized therapies are rational and that biopharmaceutical’s ability to trigger specific immune responses in patients is of key importance for successful personalized medication.
Back to About us